Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)

Autor: Alfred Mahr, Eric Hachulla, Hubert de Boysson, Nassim Guerroui, Emmanuel Héron, Stéphane Vinzio, Jonathan Broner, François-Xavier Lapébie, Martin Michaud, Laurent Sailler, Thierry Zenone, Mohamed Djerad, Mathieu Jouvray, Emilie Shipley, Nathalie Tieulie, Guillaume Armengol, Bastien Bouldoires, Jean-Francois Viallard, Isabelle Idier, Marc Paccalin, Valérie Devauchelle-Pensec

Publikováno v: Frontiers in Medicine, Vol 8 (2021)

Background: Few studies of daily practice for patients with giant cell arteritis (GCA) are available. This French study aimed to describe the characteristics and management of GCA in a real-life setting.Methods: Cross-sectional, non-interventional, m

Externí odkaz: https://doaj.org/article/ed126a2b456c41e480e94c7dc400ec8a

Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the NOH-APS cohort

Autor: Jean-Christophe Gris, Éve Mousty, Sylvie Bouvier, Sylvie Ripart, Éva Cochery-Nouvellon, Pascale Fabbro-Peray, Jonathan Broner, Vincent Letouzey, Antonia Pérez-Martin

Publikováno v: Haematologica, Vol 105, Iss 2 (2020)

Malignancies can be associated with positive antiphospholipid antibodies but the incidence of cancer among women with the purely obstetric form of antiphospholipid syndrome (APS) is currently unknown. Our aim was to investigate the comparative incide

Externí odkaz: https://doaj.org/article/4562c1767ff148449ba7d592c5c8d393

Fluidification du parcours ville-hôpital : analyse de la trajectoire des patients impliqués dans le dispositif RAPIDO après un an de mise en place

Autor: Julie Bouvet, Jonathan Broner, Erik Arnaud, Cyril Dumain, Jan Holubar, David Costa, Pierre Fesler, Marion Fages, Radjiv Goulabchand

Publikováno v: La Revue de Médecine Interne.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e7f5f4819a247752d054a016c74a8484
https://doi.org/10.1016/j.revmed.2023.04.006

Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real‐life study

Autor: Emmanuel Gyan, Pierre Fenaux, Pascale Cony-Makhoul, Odile Beyne-Rauzy, Kamel Laribi, Clémence Santana, Bohrane Slama, Jean-Thomas Giraud, Clément Gaudin, Laurence Sanhes, Ana Berceanu, Sophie Dimicoli, Amina Cherait, Berangere Gruson, Groupe Francophone des Myélodysplasies, Jose Miguel Torregrosa, Thibault Comont, Vincent Jachiet, Marie-Agnès Azerad, Mathieu Meunier, Thomas Cluzeau, Claire Guerveno, Pr Lionel Ades, Thierry Guillaume, Ahmad Al Jijakli, Lenaïg Le Clech, Jonathan Broner

Publikováno v: British Journal of Haematology. 194:336-343

Despite a moderate prevalence in low-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML), thrombocytopenia remains a risk of severe bleeding and therapeutic options are still limited. There are only a few studies with elt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::019336f92b23a5970214adc9288139fe
https://doi.org/10.1111/bjh.17539

Patients' Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World Study

Autor: Cyril Dumain, Jonathan Broner, Erik Arnaud, Emmanuel Dewavrin, Jan Holubar, Myriam Fantone, Benoit de Wazières, Simon Parreau, Pierre Fesler, Philippe Guilpain, Camille Roubille, Radjiv Goulabchand

Publikováno v: Journal of Clinical Medicine; Volume 11; Issue 11; Pages: 3115
Journal of Clinical Medicine
Journal of Clinical Medicine, 2022, 11 (11), pp.3115. ⟨10.3390/jcm11113115⟩

Objectives: Giant cell arteritis (GCA) is associated with severe outcomes such as infections and cardiovascular diseases. We describe here the impact of GCA patients’ characteristics and treatment exposure on the occurrence of severe outcomes. Meth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6189eb23743cffa7212e2883a4b361b1
https://pubmed.ncbi.nlm.nih.gov/35683507